Information
Address

Gustave Roussy
114, rue Édouard-Vaillant
94805 Villejuif Cedex - France
Switchboard:

Switchboard

+33 (0)1 42 11 42 11

GUSTAVE ROUSSY
1st cancer center in Europe

© 2006-2015 Gustave Roussy – All rights reserved

Professor Fabrice André is President-elect of the European Society for Medical Oncology (ESMO)

back to job offer list
back to clinical trials

Villejuif, 1st july 2022

Professor Fabrice André is President-elect of the European Society for Medical Oncology (ESMO)

Professor Fabrice André, Director of Research at Gustave Roussy, has been elected to the 2025-2026 presidency of the European Society for Medical Oncology (ESMO). He will assume his role within the executive committee on the 1st of January 2023.

Mélanome
06/29/2022

Dix ans d’avancées scientifiques dans les traitements du mélanome

Le traitement des mélanomes métastatiques a considérablement progressé ces dernières années grâce aux immunothérapies et traitements ciblés.
logo Des souliers pour la vie
06/22/2022

Des souliers pour la vie : une tombola au profit de la recherche contre le cancer

La Chambre Syndicale Nationale des Bottiers de France (CSNB) organise en partenariat avec Gustave Roussy une grande tombola solidaire au service de la lutte contre le cancer jusqu’au 11 janvier 2023. 
Cellule
06/16/2022

Première édition des Jeudis du Paris Saclay Cancer Cluster

Le premier des jeudis du Paris Saclay Cancer Cluster (PSCC)  se tiendra à l’Institut Polytechnique le jeudi 7 juillet.
L'essentiel de l'ASCO
06/14/2022

L'essentiel de l'ASCO 2022, par Gustave Roussy

Cette conférence aura lieu le mardi 21 Juin à 17h à Gustave Roussy et sera diffusée simultanément sur la chaine YouTube de l'Institut. 

Lucie Albert, infirmière au service des Urgences (Rouergue)

back to job offer list
back to clinical trials

Lucie Albert, infirmière au service des Urgences (Rouergue) 

ORPHELIA Pharma and Gustave Roussy announce the publication in Pharmaceuticals of the scientific work related to the development of the first temozolomide oral suspension for children

back to job offer list
back to clinical trials

Paris et Lyon, le 9 juin 2022

ASCO 2022 - 2 in 1 immunotherapy in advanced kidney cancer

back to job offer list
back to clinical trials

ASCO 2022

Dana-Farber Cancer Institute, Gustave Roussy, and L’Institut Servier sign an oncology cooperation agreement

back to job offer list
back to clinical trials

7 June 2022

Dana-Farber Cancer Institute, Gustave Roussy, and L’Institut Servier sign an oncology cooperation agreement

Paris, France, Boston, United States, 7 June 2022 – L’Institut Servier, Gustave Roussy (Villejuif, France), and Dana-Farber Cancer Institute (Boston, USA) have signed a cooperation agreement to foster exchange and develop bilateral collaboration among researchers from these two renowned oncology centers.

ASCO 2022 - The SACHA study supports the use of innovative anticancer therapies in children outside clinical trials

back to job offer list
back to clinical trials

ASCO 2022

The SACHA study supports the use of innovative anticancer therapies in children outside clinical trials  

Villejuif, 7 june 2022

Pages